FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Catalog category
KPV, LL-37, Thymalin, Thymosin Alpha-1, research peptides supporting immune-modulation and antimicrobial research.
3 actives in this category · per-lot documented · pricing on request.
What buyers source Immune & Anti-Inflammatory for, which buyer types order it, and the documentation that ships with each lot.
Sourced for
Buyer fit
Documentation that ships
Procurement note: A clean LAL result on the specific lot is the defining requirement, since many downstream assays are themselves activated by endotoxin.
Immune & Anti-Inflammatory actives
3-mer
Lys-Pro-Val α-MSH C-terminal tripeptide
37-mer
Human cathelicidin antimicrobial peptide
86-mer
28-residue immunomodulatory thymic peptide
Sold for research use only under the receiving laboratory's local regulations. Not a finished dosage form. For in vivo or cell-based assay workflows, request bacterial-endotoxin testing on the specific batch at quote stage so the COA carries the LAL value.
First response under 12 hours · Catalog · Sample COA · MOQ · Lead time. Our regulatory and sales teams review every inquiry before pricing — license verification on every request.
